Collectively, our findings illustrate that Tregs induce TGF-β-mediated EMT and subsequent metastasis of melanoma cells, suggesting that Tregs may serve as a promising therapeutic target and a predictive biomarker for melanoma metastasis. The gene discussed is TGFB1; the disease is melanoma.